Related Experiment Video
Updated: Jun 3, 2026

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Renal function and target organ damage in hypertension
Luis M Ruilope1, George L Bakris
1Hypertension Unit, Hospital 12 de Octubre, Madrid, Spain. ruilope@ad-hocbox.com
Insights
Chronic kidney disease (CKD) is common in hypertension patients. Protecting kidney function also protects cardiovascular health, using similar treatments for both conditions.
Area of Science:
- Nephrology
- Cardiology
- Hypertension Research
Background:
- Arterial hypertension and atherosclerosis share risk factors with chronic kidney disease (CKD).
- CKD is increasingly recognized as a significant factor in cardiovascular risk.
- The cardiorenal continuum highlights the interconnectedness of heart and kidney health.
Purpose of the Study:
- To examine the relationship between CKD, arterial hypertension, and cardiovascular risk.
- To emphasize the importance of renal function parameters in assessing overall health.
- To highlight the benefits of renal protection for cardiovascular outcomes.
Main Methods:
- Assessing renal function through albuminuria and estimated glomerular filtration rate (eGFR).
- Evaluating cardiovascular (CV) risk associated with microalbuminuria and decreased eGFR (<60 mL/min/1.73 m(2)).
- Analyzing the impact of CKD on hypertensive patients with pre-existing cardiovascular disease.
Main Results:
- Microalbuminuria and reduced eGFR are linked to significantly increased CV risk.
- CKD exacerbates cardiovascular events and mortality in hypertensive patients.
- Renal protection strategies are associated with improved cardiovascular protection.
Conclusions:
- CKD is a critical component of the cardiorenal continuum.
- Monitoring renal function is essential for managing cardiovascular risk in hypertensive patients.
- Treatments aimed at renal protection offer concurrent cardiovascular benefits.
Abstract:
Chronic kidney disease (CKD) is frequently observed in patients with arterial hypertension. The same factors that promote the appearance and progression of atherosclerosis can also promote the development of CKD. Two parameters are usually measured to estimate alterations in renal function, the presence of albuminuria, and the estimation of glomerular filtration rate (GFR). Microalbuminuria and a decreased estimated GFR (<60 mL/min/1.73 m(2)) are both accompanied by a significant increase in cardiovascular (CV) risk. Chronic kidney disease can develop all over the cardiorenal continuum and its presence in hypertensive patients with already developed CV disease contributes to a further increase in the development of events and death. Renal protection will in turn obtain CV protection and the treatment to be used is similar to that employed to prevent or to treat established CV disease.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Diabetic Nephropathy
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension and Regulation of Blood Pressure
Hypertension II: Pathophysiology
Antihypertensive Drugs: Direct Renin Inhibitors